Ethyl Alcohol Veterinary Grade API is a pharmacopoeial, undenatured ethanol (C₂H₆O, CAS 64-17-5, molecular weight 46.07 g/mol) manufactured and released under current good manufacturing practice as an active pharmaceutical ingredient and excipient for veterinary drug products. The material is supplied as a clear, colourless, mobile liquid with a boiling point of 78.37 °C at 101.3 kPa, a closed-cup flash point of 13 °C, an anhydrous-grade density of approximately 0.789 g/cm³ at 20 °C, and a 96% v/v grade density of approximately 0.805–0.810 g/cm³ at 20 °C. Two principal grades are available. The 96% v/v grade conforms to the Ph. Eur. monograph Ethanol 96 per centum after adjustment of the azeotrope to 95.1–96.9% v/v; the anhydrous grade is released against a not-less-than 99.5% v/v gas chromatographic specification. In tablet, capsule, and granule formulations, the 96% v/v grade functions as a granulating solvent and binder carrier. In injectable and moisture-sensitive products, the anhydrous grade is preferred to avoid water introduction. Unlike industrial ethanol, the veterinary API contains no denatonium benzoate, methanol, isopropanol, or methyl ethyl ketone. Residual solvent and impurity limits follow VICH GL18 and ICH Q3C, and bacterial endotoxin control follows USP <85> when the material is designated for parenteral use.

What Distinguishes Veterinary-Grade Ethanol from Industrial and Reagent-Grade Alcohol?

The central distinction from industrial and reagent-grade ethanol is not bulk ethanol content but the controlled absence of denaturants and the compendial impurity profile. Industrial ethanol distributed for disinfection or fuel use commonly contains denatonium benzoate, methanol, and higher alcohols; these components can produce toxic degradation products or interfere with stability-indicating high-performance liquid chromatography methods in veterinary formulations. Reagent-grade absolute ethanol may contain benzene as a drying-solvent residue and is not released against USP <467>, VICH GL18, or Ph. Eur. monograph criteria. Veterinary-grade API is produced by fermentation and multi-stage rectification or by synthetic ethylene hydration followed by purification. Manufacturing typically uses dedicated stainless-steel 316L condensers, demountable plate columns, and molecular sieve 3A dehydration for the anhydrous grade. Release testing includes gas chromatographic limits of ≤200 ppm methanol, ≤10 ppm acetaldehyde, and ≤2 ppm benzene under the Ph. Eur. monograph; for parenteral use, bacterial endotoxins are controlled to ≤0.5 EU/mL by USP <85>. In contrast, food-grade ethanol is not necessarily manufactured under current good manufacturing practice, may have higher fusel oil residues, and is not supplied with a certificate of analysis that includes residual solvent, endotoxin, and elemental impurity data. The veterinary API also differs from denatured ethanol by providing full batch traceability to production records, packaging components, and retention samples.

Compared with other alcoholic solvents used in veterinary manufacturing, ethanol has a favourable residual solvent classification and drying profile. Isopropanol is also a Class 3 solvent but has a higher boiling point of 82.6 °C, which can extend drying time in wet granulation. Methanol, although occasionally present as an impurity, is not used as a processing solvent because of its Class 2 status and acute toxicity. Propylene glycol and glycerine are used as co-solvents and plasticisers but have higher boiling points, higher viscosities, and can alter release profiles in coated granules. Ethanol is therefore selected when rapid evaporation, low viscosity, and minimal residual solvent burden are required. The distinction from food-grade alcohol appears small on certificates of analysis showing similar ethanol content, but food-grade material is not manufactured under current good manufacturing practice for pharmaceutical excipients and is not tested for bacterial endotoxins by USP <85> unless explicitly specified.

Compendial Specification Profile and Control of Impurities

The specification profile is defined by the Ph. Eur. monograph Ethanol 96 per centum, USP Alcohol, and, for anhydrous material, Ph. Eur. Ethanol anhydrous. Table 1 summarises the main release parameters for the veterinary API. Ethanol content is measured by gas chromatography using USP <611> alcohol determination or an equivalent pharmacopoeial method. Water content is determined by USP <921> Karl Fischer titration. Benzene is controlled as a Class 1 residual solvent under ICH Q3C to ≤2 ppm, while acetaldehyde is limited to ≤10 ppm because it forms Schiff-base adducts with primary amine-functional actives in liquid formulations. Residue on evaporation is controlled to ≤25 mg/L to limit non-volatile particulates in parenteral preparations. The anhydrous grade is hygroscopic and is stored under nitrogen after packaging; at ambient relative humidity above 60%, unprotected product can show measurable water uptake within 30 min because of the ethanol–water azeotrope at 95.6% w/w.

Elemental impurities are controlled under USP <232>/<233> as applicable to the dosage form and route of administration; typical release data are requested by the finished product manufacturer because ethanol is usually a minor component after drying. Microbiological quality is also controlled for non-sterile applications; the API is not intended to be sterile as supplied, but it is produced from materials with low bioburden, and the finished preparation is sterilised when required.

For oral solid dosage forms, the 96% v/v grade is metered into a high-shear granulator or top-spray fluidised bed as the liquid phase for binder dissolution and granule formation. A typical wet-granulation process for veterinary tablets uses a 500 L stainless-steel high-shear mixer at impeller speed 2–4 m/s and chopper speed 1,500–3,000 rpm; the ethanol-based binder solution is added to a dry blend of active, filler, and disintegrant over 3–8 min. Ethanol is preferred when the formulation contains water-sensitive actives or disintegrants such as crospovidone and sodium starch glycolate, because it avoids premature swelling of disintegrant particles and preserves tablet disintegration times below 15 min in USP <701>. The resulting wet mass is dried in a fluid-bed dryer at inlet air 55–65 °C to a residual ethanol level below 0.5% w/w; above this limit, tablet hardness can decline during storage because of solvent plasticisation of polymeric binders. Ethanol is a Class 3 residual solvent under VICH GL18; therefore the 0.5% w/w limit is driven primarily by process safety and physical stability rather than toxicological thresholds. At equal binder mass, ethanol-containing granulating fluids reduce surface tension relative to water, which has a surface tension of 72.8 mN/m at 20 °C, enhancing particle wetting and narrowing granule size distribution.

When Ethanol Is Used as a Co-Solvent in Injectable and Solution Manufacturing

Injectable and solution manufacturing imposes additional controls. Ethanol acts as a co-solvent by lowering the dielectric constant of water from 78.5 to 24.5 at 25 °C when present as the continuous phase modifier; this shift increases the saturated solubility of non-ionised lipophilic actives according to the extended Hildebrand solubility parameter. For parenteral-grade ethanol, the API must be filtered through a 0.22 µm sterilising-grade membrane and meet USP <85> bacterial endotoxins ≤0.5 EU/mL; terminal steam sterilisation at 121 °C for 15 min requires a container-closure study because ethanol vapour pressure can develop excessive headspace pressure. Typical injectable co-solvent concentrations range from 5% v/v to 30% v/v, with 10% v/v to 20% v/v being common in intramammary preparations and injectable solutions for cattle and swine. At concentrations above 30% v/v, precipitation risk and injection-site tolerability require case-specific evaluation; published species-specific tolerability data for this configuration are limited. For oral solutions, ethanol at 15–20% v/v functions as an antimicrobial preservative, with efficacy evaluated by USP <51> or Ph. Eur. 5.1.3.

Capsules, powders, granules, and medicated premixes generally use ethanol as a transient processing solvent rather than as a residual formulation component. In fluid-bed Wurster coating, a 10–25% w/w ethanol solution of a binding polymer or active is sprayed onto carrier pellets at an inlet temperature of 40–60 °C; the ethanol evaporates during the process, leaving a uniform active layer. Residual ethanol in finished premix and powder products is typically held below 0.3% w/w to prevent caking and microbial activity, with water activity below 0.6 measured by dew-point hygrometry. For liquid-fill hard capsules, ethanol may be used as a plug-forming solvent; the final ethanol content is controlled to <0.5% w/w and is justified under VICH GL18. The material is stored in stainless-steel or high-density polyethylene containers under nitrogen to maintain water content, and packaging is sized for single-use to avoid repeated opening and atmospheric moisture ingress.

Residual Solvent Control in Granulated Solids Requires a Defined Drying Window

For ethanol-wet granulated solids, the drying window is bounded by the boiling point of the solvent and the thermal stability of the active pharmaceutical ingredient. The lower boundary is set by the need to remove ethanol from the wet mass; the upper boundary is set by the glass transition temperature and melt point of the binder. In a fluid-bed dryer with inlet air at 55–65 °C, residual ethanol declines from 5–8% w/w to <0.5% w/w within 20–45 min for a 50 kg bed of granules. Processing below 55 °C extends drying time and increases the risk of incomplete solvent removal; processing above 65 °C can soften low-melting fillers or induce polymorphic conversion in thermolabile actives. Loss-on-drying is monitored at 105 °C until two consecutive samples differ by less than 0.1% w/w. Because ethanol is flammable with a flash point of 13 °C, the dryer is inerted to maintain oxygen below 8% v/v, and the solvent-handling area is classified in compliance with IEC 60079-10-1 zone requirements.

How Does Packaging Affect Water Content and Oxidative By-Products?

Packaging determines the long-term water content and the accumulation of oxidative by-products. The anhydrous grade is filled into 200 L stainless-steel drums or 20 L high-density polyethylene containers under nitrogen with a headspace oxygen content below 1% v/v. The 96% v/v grade may be packaged in stainless steel or high-density polyethylene, but containers must be closed immediately after dispensing because ethanol equilibrates with atmospheric moisture. Oxidative degradation of ethanol to acetaldehyde and acetic acid is accelerated by light, air, and trace transition metals; therefore amber glass is used for 1 L and 2.5 L laboratory packs. Storage at 15–25 °C in a fire-rated solvent store is required; ignition sources are excluded because the material has a flash point of 13 °C and a vapour explosion range of 3.3–19.0% v/v in air. Peroxide formation is not a primary degradation pathway for ethanol, but the product is not combined with strong oxidising agents such as potassium permanganate because exothermic oxidation can generate acetaldehyde and acetic acid.

The veterinary-grade ethanol is incompatible with strong oxidising agents, concentrated nitric acid, and certain packaging elastomers that leach plasticisers. It should not be used with denatured alcohol dispensing systems because cross-contamination with denatonium benzoate or methanol can compromise compendial compliance. For formulations containing amine-functional actives, acetaldehyde content should be monitored during long-term storage; acetaldehyde can form coloured enamines and imine adducts. In freeze-dried veterinary products, ethanol is generally removed prior to lyophilisation unless it is present as a residual solvent with a validated limit. Published data for the use of anhydrous ethanol in sustained-release implants is limited; therefore formulation-specific compatibility, local tolerance, and residual solvent validation are required before use.